Market News How it works Learn FAQ
| GPUS 0.1689 34.05% | SHFS 0.1324 -61.39% | XXII 0.1977 -8.34% | NVD 4.19 0.96% | LUCD 0.411 25.42% | SPCX 147.49 1.89% | T 20.93 -7.96% | SOXL 83.56 1.77% | NU 15.16 2.92% | NOK 8.14 3.30% | EWZ 42.59 1.77% | NVDA 210.96 -0.59% | RIME 0.106 -12.90% | INTC 86.96 1.72% | TSLG 4.87 -1.62% | AAL 12.11 -3.89% | BBD 4.07 3.04% | STLA 4.06 -4.81% | SOXS 52.46 -1.85% | RWM 14.55 0.34% | HYG 77.05 -0.06% | MYND 0.24 47.42% | RBNE 0.19 -2.56% | YFOR 0.2236 -1.58% | BITO 10.83 -0.28% | SPDN 8.54 0.47% | TQQQ 66.29 -0.20% | TSLL 9.76 -1.21% | VZ 44.66 -1.19% | SPTI 27.63 -0.11% | YMAT 2.05 6.77% | CRWV 54.235 -2.46% | INFY 12.35 -6.58% | RIG 6.41 5.43% | F 11.6 -2.85% | GRAB 2.79 -2.11% | AIOK 12.02 182.82% | SQQQ 39.68 0.20% | ONDS 6.2 2.99% | LABT 0.31 -36.67% | AAPL 347.725 -0.14% | CDE 13.45 -3.10% | PCG 12.63 -2.70% | IREN 24.905 -2.37% | SOFI 14.615 -1.05% | XLE 69.33 2.60% | NFLX 65.85 -1.79% | QID 14.55 0.14% | CLRO 3.25 69.27% | WULF 11.32 0.00%
PRProcaps Group S.A. logo

Procaps Group S.A. (PROC)

NASDAQ Global Market · Currency in USD
$1.01 ▲ +1.01 (+100.00%)
At close: Mar 12, 4:00 PM ET. Market closed.

Summary

Previous Close
$1.01
Open
$1.01
Day's Range
$1.01 – $1.01
52 Week Range
$0.50 – $3.78
Volume
652,298
Avg. Volume
114,297
Market Cap
$102.08M
Beta (5Y Monthly)
0.17
PE Ratio (TTM)
2.40
EPS (TTM)
$0.42
Earnings Date
--
Forward Dividend & Yield
--
Ex-Dividend Date
--
1y Target Est
$10.00

Profile: Procaps Group S.A.

Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Full-time employees
5,500
CEO
Jose Antonio Toledo Vieira

Procaps Group S.A., established in Luxembourg in 1977, functions as a global pharmaceutical enterprise dedicated to the creation, production, and distribution of a broad spectrum of pharmaceutical solutions. The company manufactures and markets branded prescription medications addressing diverse therapeutic needs, including women's health, pain management, dermatological conditions, digestive disorders, growth and development, cardiovascular care, vision health, central nervous system ailments, and respiratory issues. In addition to prescription drugs, Procaps supplies a suite of products for hospital use, encompassing antibiotics, anticoagulants, personal protective equipment, immunosuppressants, oncology treatments, and analgesics.

Earnings

DateEst.Actual
Dec 31, 2024–$0.08
Dec 24, 2024–$0.08
Dec 26, 2023$0.05$0.08Beat
Nov 14, 2023$0.05$0.08Beat
Sep 5, 2023$0.06$0.27Beat
Jun 5, 2023-$0.04$0.07Beat

Analyst view

Consensus price target
$10.00 ▲ +890.1%
Range $10.00 – $10.00
Rating: Hold
Buy 0% · Hold 100% · Sell 0%

Get free alerts on PROC and big market moves

Free special alerts by text & email on new investment opportunities, buyouts and the stocks moving most, in plain English.
Get free stock alerts →
Data: Financial Modeling Prep. For information only, not investment advice.